2. Academic Validation
  3. Modulation of KRAS Mutant by Inhibiting PLK1 Kinase in Cancer Therapeutics

Modulation of KRAS Mutant by Inhibiting PLK1 Kinase in Cancer Therapeutics

  • ACS Med Chem Lett. 2021 Sep 15;12(10):1514-1516. doi: 10.1021/acsmedchemlett.1c00442.
Robert B Kargbo 1
Affiliations

Affiliation

  • 1 Usona Institute, 277 Granada Drive, San Luis Obispo, California93401-7337, United States.
PMID: 34676025 DOI: 10.1021/acsmedchemlett.1c00442
Figures
Products